Source comparison
Sermorelin Sleep Research: Dose Comparison
100 mcg 10–15% above baseline 0–5 minutes None reported $80–$120 Below therapeutic threshold. Insufficient for measurable sleep architecture changes 200 mcg 25–35% above baseline 8–12 minutes Rare mild flushing $140–$180 Minimum effective dose for sleep latenc
This comparison does not assign a generated winner or score.
- 100 mcg
- 10–15% above baseline
- 0–5 minutes
- None reported
- $80–$120
- Below therapeutic threshold. Insufficient for measurable sleep architecture changes
- 200 mcg
- 25–35% above baseline
- 8–12 minutes
- Rare mild flushing
- $140–$180
- Minimum effective dose for sleep latency improvement. Suitable for initial titration
- 300 mcg
- 50–70% above baseline
- 18–25 minutes
- Occasional injection site reaction
- $200–$260
- Standard research dose. Optimal balance between efficacy and tolerability for most protocols
- 400 mcg
- 70–90% above baseline
- 22–30 minutes
- Transient headache (10–15%)
- $260–$340
- Upper therapeutic range. Used when 300 mcg shows partial response
- 500 mcg
- 85–100% above baseline
- 25–32 minutes
- Headache, flushing (20–25%)
- $320–$420
- Dose ceiling. Receptor saturation plateaus benefit; higher cost-per-minute sleep gain
- 750+ mcg
- Minimal additional response
- No further increase
- Increased adverse events
- $480+
- Beyond therapeutic window. No sleep architecture benefit, elevated side effect risk